Anthonius de Boer

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

British journal of clinical pharmacology

Clinical pharmacology and therapeutics

Journal of medical Internet research

European psychiatry : the journal of the Association of European Psychiatrists

Medicines Evaluation Board

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medicines Evaluation Board Aug 01 2017

Netherlands

Chair

Universiteit Utrecht Jan 01 1992

Netherlands

Professor of Pharmacotherapy :: Pharmaceutical Sciences

Publications

Marieke S Jansen, Olaf M Dekkers, Saskia Le Cessie, Lotty Hooft, Helga Gardarsdottir, Anthonius de Boer, Rolf H H Groenwold
Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review. Clinical pharmacology and therapeutics 115 (6) (2024)
Sem E Cohen, Jasper Brian Zantvoord, Taina K Mattila, Bram W C Storosum, Anthonius de Boer, Damiaan A J P Denys
The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Marieke S Jansen, Olaf M Dekkers, Saskia Le Cessie, Lotty Hooft, Helga Gardarsdottir, Anthonius de Boer, Rolf H H Groenwold
Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review. Clinical pharmacology and therapeutics 115 (6) (2024)
Marieke S Jansen, Olaf M Dekkers, Saskia Le Cessie, Lotty Hooft, Helga Gardarsdottir, Anthonius de Boer, Rolf H H Groenwold
Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review. Clinical pharmacology and therapeutics (2024)
Amos J de Jong, Yared Santa-Ana-Tellez, Mira G P Zuidgeest, Renske J Grupstra, Fatemeh Jami, Anthonius de Boer, Helga Gardarsdottir, null null
Direct-to-Participant Investigational Medicinal Product Supply in Clinical Trials in Europe - Exploring the Experiences of Sponsors, Site Staff, and Couriers. British journal of clinical pharmacology (2023)
Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier, Caspar van Loosen, Anna Maria Gerdina Pasmooij, Maaike van Dartel, Alfonsus J M van den Eertwegh, Anthonius de Boer, Michel W J M Wouters, Doranne Hilarius
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis. Journal of medical Internet research 24 (6) (2022)
M Mirjam Hempenius, Simone Rijken, Rolf H H Groenwold, Karin Hek, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study. British journal of clinical pharmacology (2022)
Diana A van Riet-Nales, Katarina Sundberg, Anthonius de Boer, Blanka Hirschlérova
Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population. British journal of clinical pharmacology 86 (10) (2021)
Talip E Eroglu, Carlo Alberto Barcella, Marieke T Blom, Grimur H Mohr, Patrick C Souverein, Christian Torp-Pedersen, Fredrik Folke, Mads Wissenberg, Anthonius de Boer, Peter J Schwartz, Gunnar H Gislason, Hanno L Tan, null null
Out-of-hospital cardiac arrest and differential risk of cardiac and non-cardiac QT-prolonging drugs in 37 000 cases. British journal of clinical pharmacology (2021)
M Mirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact. Pharmacoepidemiology and drug safety 30 (12) (2021)
Talip E Eroglu, Lixia Jia, Marieke T Blom, Arie O Verkerk, Harsha D Devalla, Gerard J J Boink, Patrick C Souverein, Anthonius de Boer, Hanno L Tan
Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: Real-world data from a population-based study. British journal of clinical pharmacology 87 (9) (2021)
M Mirjam Hempenius, Rolf H H Groenwold, Patrick C Souverein, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants. British journal of clinical pharmacology 87 (9) (2021)
Sven Stegemann, Diana A van Riet-Nales, Anthonius de Boer
Demographics in the 2020s-Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life. British journal of clinical pharmacology 86 (10) (2021)
Talip E Eroglu, Carlo Alberto Barcella, Marieke T Blom, Patrick C Souverein, Grimur H Mohr, Christian Torp-Pedersen, Fredrik Folke, Mads Wissenberg, Anthonius de Boer, Gunnar H Gislason, Hanno L Tan, null null
Opioid use is associated with increased out-of-hospital cardiac arrest risk among 40,000-cases across two countries. British journal of clinical pharmacology (2021)
Rianne A Weersink, Marianna Abadier, Anthonius de Boer, Katka Taxis, Sander D Borgsteede
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients. British journal of clinical pharmacology 86 (4) (2020)
Diana A van Riet-Nales, Linda Donkerbroek, Agnes Nicia, Christien Oussoren, Anthonius de Boer, Bart van den Bemt
The development of a test battery to assess the hand-eye functions relevant in predicting easy and accurate tablet subdivision in older people: A pilot study. British journal of clinical pharmacology 86 (10) (2020)
Yumao Zhang, Patrick C Souverein, Helga Gardarsdottir, Hendrika A van den Ham, Anke-Hilse Maitland-van der Zee, Anthonius de Boer
Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. British journal of clinical pharmacology 86 (6) (2020)
Jeroen P A Houwen, Antoine C G Egberts, Anthonius de Boer, Erik M van Maarseveen, Roderick H J Houwen, Arief Lalmohamed
Influence of allopurinol on thiopurine associated toxicity: A retrospective population-based cohort study. British journal of clinical pharmacology 87 (5) (2020)
Thomas O Bergmeijer, Alfi Yasmina, Gerrit J A Vos, Paul W A Janssen, Christian M Hackeng, Johannes C Kelder, Shefali S Verma, Marylyn D Ritchie, Li Gong, Teri E Klein, null Icpc Investigators, Anthonius de Boer, Olaf H Klungel, Jurriën M Ten Berg, Vera H M Deneer
Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. Genes 11 (9) (2020)
Florence P A M van Hunsel, Helga Gardarsdottir, Anthonius de Boer, Agnes Kant
Measuring the impact of pharmacovigilance activities, challenging but important. British journal of clinical pharmacology 85 (10) (2019)
Christine Gispen-de Wied, Anthonius de Boer
Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al. British journal of clinical pharmacology 84 (8) (2018)
Seyed Hamidreza Mahmoudpour, Folkert W Asselbergs, Patrick C Souverein, Anthonius de Boer, Anke H Maitland-van der Zee
Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study. British journal of clinical pharmacology 84 (10) (2018)

Anthonius de Boer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anthonius de Boer